Farther Finance Advisors, LLC Supernus Pharmaceuticals, Inc. Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
A detailed history of Farther Finance Advisors, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 62 shares of SUPN stock, worth $2,082. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62
Previous 152
59.21%
Holding current value
$2,082
Previous $4.82 Million
59.42%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SUPN
# of Institutions
302Shares Held
60.7MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$349 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$207 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$175 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$97.5 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$90.7 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.8B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...